APA (7th ed.) Citation

V, R., SH, O., E, O., CL, S., AJ, E., A, M., . . . LG, M. (2025). Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia. Blood advances, 9(18), 4738. https://doi.org/10.1182/bloodadvances.2025016160

Chicago Style (17th ed.) Citation

V, Rodriguez, O'Brien SH, Orgel E, Schultz CL, Esbenshade AJ, Memaj A, Dyme JL, Favatella NA, and Mitchell LG. "Safety and Efficacy of Apixaban Thrombosis Prevention in Pediatric Patients with Obesity and Acute Lymphoblastic Leukemia." Blood Advances 9, no. 18 (2025): 4738. https://doi.org/10.1182/bloodadvances.2025016160.

MLA (9th ed.) Citation

V, Rodriguez, et al. "Safety and Efficacy of Apixaban Thrombosis Prevention in Pediatric Patients with Obesity and Acute Lymphoblastic Leukemia." Blood Advances, vol. 9, no. 18, 2025, p. 4738, https://doi.org/10.1182/bloodadvances.2025016160.